Phosphagenix raises $4m in UK placement
Wednesday, 03 November, 2004
Phosphagenics (ASX:POH) has raised £1.75 million (AUD$4.3 million) through a placement of about 18 million shares in the UK.
It's the second placement the company has done in the UK this year -- in late July the company raised almost AUD$850,000 through a placement at the same time as it announced plans to list on the London Stock Exchange's Alternative Investment Market (AIM).
CEO Ian Patterson said the new placement indicated Phosphagenics' commitment to establishing itself as an international company and to listing on AIM. The funds will be used to accelerate and extend development of Phosphagenics' pharmaceutical program.
Saliva-based biosensor could improve heart failure detection
Scientists have created a biosensor that can rapidly detect the heart failure biomarker S100A7 in...
Melanoma-causing mutation can lie dormant in healthy skin
Researchers found many examples of the mutation in normal skin, including skin next to a mole and...
Antibiotic for drug-resistant bacteria found in plain sight
The antibiotic in question is an intermediate chemical in the natural process that produces the...
